Ocular Surface Disease

Moving beyond the drop: CEO provides updates on Oyster Point's pipeline

Jeff Nau, PhD, MMS, President and CEO of Oyster Point Pharmaceuticals, provides an appraisal of the company's pipeline as well as updates on recent innovations to hit the market.

More ocular symptoms found in smokers who used cigarettes than e-cigarettes

Those who used both traditional and electronic cigarettes reported severe to very severe ophthalmic symptoms.

Eyes with ocular involvement from SJS/TEN mandate acute and chronic care

Patients are at risk for developing severe dry eye and ocular surface disease.

Taping surgical masks to the skin decreases risk of ocular surface damage during the COVID-19 pandemic

May 02, 2022

During a presentation at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Yuichi Hori, MD, PhD, and colleagues found that taping the top border of a surgical mask to a clinicians’ skin reduces the potential for ocular surface damage resulting from expirations of air reaching the ocular surface during the COVID-19 pandemic.

Study examines high performance microscopy for non-invasive conjunctival goblet cell examination

April 08, 2022

A team of investigators from Pohang University of Science and Technology has found that conjunctival goblet cell examination is important for the precise diagnosis and effective treatment of ocular surface diseases; however, CGC examination has not been possible until now due to lack of non-invasive devices.